cytosine has been researched along with Nasopharyngeal Neoplasms in 6 studies
Nasopharyngeal Neoplasms: Tumors or cancer of the NASOPHARYNX.
Excerpt | Relevance | Reference |
---|---|---|
"The effect of the antiviral agent (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine (cidofovir) on the EBV-associated tumor nasopharyngeal carcinoma (NPC) was evaluated in NPC xenografts in athymic mice." | 7.70 | The antiviral agent cidofovir [(S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine] has pronounced activity against nasopharyngeal carcinoma grown in nude mice. ( De Clercq, E; Neyts, J; Pagano, JS; Raab-Traub, N; Sadler, R, 1998) |
"The effect of the antiviral agent (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine (cidofovir) on the EBV-associated tumor nasopharyngeal carcinoma (NPC) was evaluated in NPC xenografts in athymic mice." | 3.70 | The antiviral agent cidofovir [(S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine] has pronounced activity against nasopharyngeal carcinoma grown in nude mice. ( De Clercq, E; Neyts, J; Pagano, JS; Raab-Traub, N; Sadler, R, 1998) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 5 (83.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, H | 1 |
Zhang, L | 1 |
Niu, Z | 1 |
Zhou, M | 1 |
Peng, C | 1 |
Li, X | 1 |
Deng, T | 1 |
Shi, L | 1 |
Tan, Y | 1 |
Li, G | 1 |
Abdulkarim, B | 1 |
Sabri, S | 1 |
Zelenika, D | 1 |
Deutsch, E | 1 |
Frascogna, V | 1 |
Klijanienko, J | 1 |
Vainchenker, W | 1 |
Joab, I | 1 |
Bourhis, J | 1 |
Wakisaka, N | 2 |
Yoshizaki, T | 2 |
Raab-Traub, N | 3 |
Pagano, JS | 3 |
Kondo, S | 1 |
Murono, S | 2 |
Shimizu, Y | 1 |
Nakashima, M | 1 |
Tsuji, A | 1 |
Furukawa, M | 1 |
Neyts, J | 1 |
Sadler, R | 1 |
De Clercq, E | 1 |
6 other studies available for cytosine and Nasopharyngeal Neoplasms
Article | Year |
---|---|
Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells.
Topics: Base Sequence; Binding Sites; Carcinoma; Cell Line, Tumor; Chromosomal Proteins, Non-Histone; CpG Is | 2008 |
Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
Topics: Animals; Antiviral Agents; Apoptosis; bcl-2-Associated X Protein; Burkitt Lymphoma; Carcinoma; Caspa | 2003 |
Ribonucleotide reductase inhibitors enhance cidofovir-induced apoptosis in EBV-positive nasopharyngeal carcinoma xenografts.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma; Cidofovir; Cytosine; Drug Interactions; Enzyme | 2005 |
Treatment of locally recurrent Epstein-Barr virus-associated nasopharyngeal carcinoma using the anti-viral agent cidofovir.
Topics: Adult; Antineoplastic Agents; Antiviral Agents; Cidofovir; Cytosine; Epstein-Barr Virus Infections; | 2008 |
The antiviral agent cidofovir [(S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine] has pronounced activity against nasopharyngeal carcinoma grown in nude mice.
Topics: Adolescent; Animals; Antiviral Agents; Apoptosis; Carcinoma; Cidofovir; Cytosine; Drug Screening Ass | 1998 |
Prevention and inhibition of nasopharyngeal carcinoma growth by antiviral phosphonated nucleoside analogs.
Topics: Adenine; Animals; Antineoplastic Agents; Apoptosis; Carcinoma; Cell Division; Cidofovir; Cytosine; E | 2001 |